Different methods to counteract mycotoxin production and its impact on animal health by Devreese, Mathias et al.
METHODS TO COUNTERACT MYCOTOXINS
Mycotoxins are secondary metabolites produced 
by several fungal species on feed and foodstuffs. They 
can exert distinguished toxic effects on several animal 
species, and may lead to great economic losses in ani-
mal husbandry. Because of their detrimental effects, a 
number of strategies have been developed to 1. reduce 
the growth of mycotoxigenic fungi and mycotoxin 
production, 2. detoxify contaminated feed and 3. lower 
the systemic availability once mycotoxins are ingested 
by the animal.
    
Pre- and post-harvesting strategies
Mycotoxin contamination may occur in the fi eld, 
pre-harvesting period, or during storage and proces-
sing, the post-harvesting period. Methods for preven-
ting mycotoxicosis in animals may therefore be di-
vided into pre- or post-harvesting strategies. Certain 
methods have been found to signifi cantly reduce speci-
fi c mycotoxins. However, the complete eradication of 
mycotoxin contamination is currently not achievable 
(Kabak et al., 2006).
The most important strategy for pre-harvesting is 
the application of Good Agriculture Practices (GAP). 
Appropriate GAP includes crop rotation, tillage, ir-
rigation and the proper use of chemicals. Crop rota-
tion is important and is focused on breaking the chain 
of infectious material, for example by wheat-legume 
rotations. Including maize in the rotation should be 
avoided, as maize is very susceptible to Fusarium spp. 
infestations. Any cultivation process that includes des-
truction and the removal of the burial of the infected 
crop is regarded as good soil cultivation. The deeper 
the soil is inverted (ploughing), the less plausible fungi 
growth will be on the following crop (Edwards, 2004). 
Irrigation is also valuable to prevent fungi infestation 
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     BSTRACT
Mycotoxins can cause serious adverse effects on animal health. This may lead to great economic 
losses in animal husbandry. In this review, the most common methods to counteract mycotoxins 
are presented, including several pre- and post-harvest strategies as well as an overview of the 
different mycotoxin detoxifying agents. The current legislation regarding maximum, guidance 
or action levels of mycotoxin contamination in various feedstuffs is also mentioned. It allows the 
agricultural industry to interpret feed analysis results and to decide whether to undertake actions 
or not. 
SAMENVATTING
De aanwezigheid van mycotoxines in veevoeder kan aanzienlijke schade aan de diergezondheid toe-
brengen. Dit kan tot beduidende economische verliezen leiden voor de veehouderij. In dit overzichtsar-
tikel worden de belangrijkste maatregelen weergegeven om mycotoxineproductie tegen te gaan en haar 
effect op de diergezondheid te verminderen. Zowel de mogelijke maatregelen vóór als na de oogst en 
een overzicht van de verschillende mycotoxine-detoxifi cerende producten worden besproken. De huidige 
wetgeving met betrekking tot maximum toegelaten gehaltes of indicatieve waarden van mycotoxines in 
verschillende voeders wordt eveneens vermeld. Deze wetgeving stelt de landbouwindustrie in staat om 
de resultaten van voederanalysen te interpreteren en te beslissen om al dan niet maatregelen te treffen.
A
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by reducing plant stress. All plants in the fi eld need 
an adequate water supply; however, excess irrigation 
during fl owering (anthesis) makes conditions favo-
rable for Fusarium infection (Codex Alimentarius, 
2002). Another factor which is known to increase the 
susceptibility of agricultural commodities to mold in-
vasion is damage due to birds, lepidopteran insects 
or rodents. Insect damage and consequent fungal in-
fection must be controlled by the appropriate use of 
insecticides and fungicides. This should be integrated 
with an adequate pest management control (Codex 
Alimentarius, 2002).
All these parameters can be controlled; however, 
environmental conditions can not. Relative humidity 
and temperature are known to have an important onset 
on mold infection and mycotoxin production. Drought 
damaged plants are shown to be more susceptible to in-
fection, so crop planting should be timed to avoid high 
temperatures and drought (Kabak et al., 2006). For 
Fusarium spp. infection however, suffi cient moisture 
conditions at anthesis are critical for the onset of Fu-
sarium head blight (FHB) (Aldred and Magan, 2004).
Post-harvest storage conditions are essential in 
preventing mold growth and mycotoxin production 
(Schrodter, 2004). For example, grains should be sto-
red with less than 15% moisture content to avoid hot-
spots with high moisture, favorable for mold growth. 
Before storage, visibly damaged or infected grains 
should be removed. However, this method is not ex-
haustive or very specifi c (Jard et al., 2011), and multi-
ple reduction strategies should be combined.
Several chemical detoxifi cation methods have also 
been described. In all cases, they should destroy or 
inactivate mycotoxins, generate non-toxic products, 
warrant the nutritional value of the food and feed, and 
should not induce modifi cation to the technical proper-
ties of the product (Jard et al., 2011). The wide variety 
of chemical decontamination processes include radia-
tion, oxidation, reduction, ammonization, alkalization, 
acidifi cation and deamination (Kabak et al., 2006). 
These chemical methods are not allowed in the Euro-
pean Union (European Commission, 2001) as chemi-
cal transformation might lead to toxic derivatives. In 
the United States of America, only ammonization is 
licensed for detoxifying afl atoxins.
      
Mycotoxin detoxifying agents
The use of many of the previously described me-
thods for the detoxifi cation of agricultural commodities 
is restricted due to associated problems. An alternative 
approach to reduce the exposure to mycotoxins in feed 
is to decrease the bioavailability by the inclusion of 
mycotoxin detoxifying agents (mycotoxin detoxifi -
ers) in the feed. This method is the most commonly 
used today (Jard et al., 2011; Kolosova and Stroka, 
2011). These detoxifi ers can be divided into two dif-
ferent classes, namely mycotoxin binders and myco-
toxin modifi ers. An overview of the different products 
covered by both classes is given in Table 1. These 
two classes have different modes of action. Myco-
toxin binders adsorb the toxin in the gut, resulting in 
the excretion of a toxin binder complex in the feces, 
whereas mycotoxin modifi ers transform the toxin into 
non-toxic metabolites (EFSA, 2009). In 2009, the ex-
tensive use of these additives led to the establishment 
of a new group of feed additives: ‘substances for re-
duction of the contamination of feed by mycotoxins: 
substances that can suppress or reduce the absorp-
tion, promote the excretion of mycotoxins or modify 
their mode of action’ (European Commission, 2009). 
It should be pointed out that the use of such products 
does not mean that animal feed exceeding maximal 
regulatory limits may be used. Their use should rather 
improve the quality of the feed which is lawfully on 
the market, providing additional guarantees for animal 
health safety (Kolosova and Stroka, 2011).
Mycotoxin binders
Mycotoxin binders (adsorbing or sequestering 
agents) are large molecular weight compounds that 
are able to bind the mycotoxins in the gastrointesti-
nal tract of the animal. In this way, the toxin binder 
complex passes through the animal, and is eliminated 
via the feces. This prevents or minimizes the expo-
sure of animals to mycotoxins. Mycotoxin binders are 
mainly divided in silica-based inorganic compounds or 
carbon-based organic polymers (EFSA, 2009).
    
Inorganic binders
The effi cacy of inorganic binders depends on 
the chemical structure of both the adsorbent and the
mycotoxin. The most important feature is the physical 
structure of the adsorbent, i.e. the total charge and 
charge distribution, the size of the pores and the acces-
sible surface area. On the other hand, the properties of 
the adsorbed mycotoxins, such as polarity, solubility, 
shape and charge distribution, also play a signifi cant 
role. Generally speaking, the binding capacity increa-
ses with surface area and chemical affi nities between 
adsorbent and mycotoxin (Avantaggiato et al., 2005; 
Huwig et al., 2001; Kabak et al., 2006).
Aluminosilicate minerals (clays) are the largest 
class of mycotoxin binders, and most of the studies on 
the alleviation of mycotoxicosis by the use of adsor-
bents have been focused on these clays. Within this 
group, there are two different subclasses: the phyllo-
silicate subclass and the tectosilicate subclass. Phyl-
losilicates include bentonites, montmorillonites, smec-
tites, kaolinites and illites. The tectosilicates include 
zeolites (EFSA, 2009). Montmorillonite is primarily 
a layered phyllosilicate composed of layers of octa-
hedral aluminum and tetrahedral silicon coordinated 
with oxygen atoms. Bentonite is generally an impure 
clay consisting mostly of montmorillonite. Zeolites 
are composed of tetrahedrons of SiO4 and AlO4 pos-
sessing an infi nite three-dimensional cage-like struc-
ture. In these minerals, some of the tetravalent silicon 
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are replaced by trivalent aluminum giving rise to a 
defi ciency of positive charge, which is balanced by 
inorganic cations, such as sodium, calcium and potas-
sium ions.  Hydrated sodium calcium aluminosilicate 
(HSCAS) contains calcium ions and protons, which 
are exchanged against the naturally occurring sodium 
ions (Huwig et al., 2001). This HSCAS is a heat pro-
cessed and purifi ed montmorillonite clay. It was deve-
Mycotoxin binders Inorganic Aluminosilicates
           Phylosilicates
                                  Bentonites
                                  Montmorillonites
                                  HSCAS
                                  Smectites
                                  Kaolinites
                                  Illites
           Tectosilicates
                                  Zeolites
  Activated charcoal  
  Synthetic polymers
            Dietary fi bre 
            Polyvinylpyrrolidone 
            Cholestyramine 
 Organic Saccharomyces cerevisiae
            Live yeast 
            Yeast cell wall components
                                  Glucomannans  
  Lactic acid bacteria
            Lactococcus 
            Lactobacillus 
            Leuconostoc 
            Pediococcus 
    
Mycotoxin modifi ers Bacteria Eubacterium BBSH 797  
  Nocardia asteroides  
  Corynebacterium rubrum  
  Mycobacterium fl uoranthenivorans  
  Rhodococcus erythropolis  
  Flavobacterium aurantiacum  
  Pseudomonas fl uorescens  
  …  
 Yeast Trichosporon mycotoxinivorans  
  Phaffi a rhodozyma  
  Xanthophyllomyces dendrorhous  
  Saccharomyces cerevisiae
  …  
 Fungi Aspergillus sp. A. fl avus 
   A. niger 
  Rhizopus sp. R. stolonifer 
   R. oryzae 
   R. microsporus 
  Penicillium raistrickii  
  Exophalia spinifera  
  Rhinocladiella atrovirens  
  …  
 Enzymes Epoxidase  
  Lactonohydrolase or Lactonase  
  Carboxypeptidase A  
  α-Chymotrypsin  
  Carboxylesterase
Table 1. Overview of the different classes and subclasses of mycotoxin detoxifi ers (adapted from EFSA (2009)).
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loped by Phillips et al. (1988) and commercialized as
NovaSil®. Clay products, including bentonites, zeoli-
tes and HSCAS, are the most common feed additives 
effective in binding afl atoxins in vitro as well as in 
vivo (Kabak et al., 2006). Because of their fairly non-
polar properties, they lack the ability of adsorbing Fu-
sarium mycotoxins, such as fumonisins, zearalenone 
(ZON) and trichothecenes, as well as ochratoxin A 
(OTA) (Avantaggiato et al., 2005; Kabak et al., 2006; 
Phillips et al., 2008). HSCAS has a lamellar interlayer 
structure in which the planar afl atoxin B1 (AFB1)
can be bound. The interaction is based on the negative 
charge of the clay with the partly positive charged 
dicarbonyls of AFB1 (Phillips et al., 2008). Although 
the mentioned clays have proven to be effective in 
preventing afl atoxicosis in various animal species, se-
veral disadvantages should be considered. They do
not exert any binding potential towards other myco-
toxins, they can adsorb vitamins and minerals, and the 
risk of natural clays to be contaminated with dioxins 
should also be considered (Huwig et al., 2001; Jouany, 
2007).
Another inorganic sorbent of interest is activated 
charcoal, also called active carbon (AC). AC is a non-
soluble powder formed by pyrolysis of several organic 
compounds. It is manufactured by an activation process 
to develop a highly porous structure (Galvano et al., 
2001). The sequestrant properties of AC depend on 
many factors, including pore size, surface area, struc-
ture of the mycotoxin and dose. The surface-to-mass 
ratio of AC varies from 500 to 3500 m2/g. AC has 
been shown to be an effective binder of a wide variety 
of drugs and toxic agents. It has been commonly used
as a medical treatment for severe intoxications since
the 19th century (Huwig et al., 2001). AC has been pro-
ven an effective adsorbent of deoxynivalenol (DON), 
ZON, AFB1, fumonisin B1 (FB1) and OTA (Avan-
taggiato et al., 2004; Devreese et al., 2012; Huwig et 
al., 2001). Nevertheless, its unspecifi c binding is the 
major drawback in the practical use of AC as a feed
additive. It diminishes nutrient absorption, such as vita-
mins and minerals, and consequently impairs the nutri-
tional value of feed (Avantaggiato et al., 2004; Ramos 
et al., 1996).
Polymers are another group of inorganic myco-
toxin binders. Several agents belong to this group, 
such as dietary fi bre and polyvinylpyrrolidone (highly 
polar amphoteric polymer), but the most well-known 
is cholestyramine. Cholestyramine is an insoluble, 
quaternary ammonium anion exchange resins, which 
strongly binds anionic compounds (Underhill et al., 
1995). It has been used as drug in humans for absor-
bing bile acids in the gastrointestinal tract in order to 
reduce cholesterol. This compound has been proven to 
be an effective binder for FB1, OTA and ZON in vitro 
(Avantaggiato et al., 2003; Avantaggiato et al., 2005; 
Döll et al., 2004; Ramos et al., 1996). The cost of po-
lymers is high, limiting their practical use in animal 
feed (Kolosova and Stroka, 2011).
Organic binders
Organic mycotoxin binders which are commonly 
used are cell wall components from Saccharomy-
ces cerevisiae yeasts. By using only yeast cell walls 
(composed of β-glucans and mannan oligosaccha-
rides) instead of the whole cell, mycotoxin binding 
can be enhanced. The fact that dead cells do not lose 
their binding ability shows that the interaction of such 
products with mycotoxins is by adhesion to cell wall 
components rather than by covalent binding or by me-
tabolism (Shetty and Jesperson, 2006). It has recently 
been demonstrated that the β-D-glucan fraction of 
yeast cell wall is directly involved in the binding pro-
cess with ZON, and that the structural organization of 
β-D-glucans modulates the binding strength. Hydrogen 
and van-der-Waals bonds have been evidenced in the 
glucans-mycotoxin complexes (Jouany, 2007; Shetty 
and Jespersen, 2006; Yiannikouris et al., 2004; Yian-
nikouris et al., 2006). Based on in vitro assays, this 
glucomannan (GMA) binder has shown to effectively 
bind DON, T-2 toxin (T-2), ZON, OTA and AFB1 
(Bejaoui et al., 2004; Freimund et al., 2003; Yiannikou-
ris et al., 2004; Yiannikouris et al., 2006). Protective 
effects of GMA against the detrimental consequences 
of mycotoxins on animal production parameters have 
been demonstrated in several studies: Raju and Deve-
gowda (2000) demonstrated that GMA has benefi cial 
effects in broilers when included in feed contaminated 
with AFB1 (0.3 mg/kg), OTA (2 mg/kg) and T-2 (3 
mg/kg). In the study, individual and combined effects 
of these mycotoxins were examined. Signifi cant inter-
actions were observed between any two mycotoxins, 
such as additive effects on body weight or feed intake, 
or antagonistic effects on serum protein and serum 
cholesterol content. The GMA incorporation increased 
body weight and feed intake, decreased liver weight, 
and improved some serum biochemical and hemato-
logical parameters which were negatively infl uenced 
by the mycotoxins in the feed (Raju and Devegowda, 
2000). These binders also alleviate the adverse effects 
of AFB1 (1 mg/kg) on performance, liver weight and 
mortality in broiler chickens (Kamalzadeh et al., 2009). 
GMA counteracts most of the plasma parameter alte-
rations caused by a DON contaminated diet (3 mg/
kg) in chickens (Faixova et al., 2006). Aravind et al. 
(2003) showed a protective effect of GMA against anti-
oxidant depletion in chicken livers caused by the intake 
of T-2 contaminated (8 mg/kg) diet. Some positive 
effects of these products have also been demonstrated 
in pigs. In a study by Diaz-Llano and Smith (2007), 
GMA was able to counteract the alterations of serum 
biochemical parameters induced by DON (5.5 mg/kg) 
in sows. However, no positive effect on feed intake and 
body weight gain was seen. Furthermore, Dänicke et al. 
(2007) did not observe improved performance in pigs 
due to GMA addition in a DON contaminated feed (4.4 
mg/kg). However, Nesic et al. (2008) did observe im-
proved performance of pigs when GMA was included 
in the diet compared to a diet only contaminated with 
ZON at 3.8 and 5.2 mg/kg.
Another group of organic mycotoxin binders, which 
have recently become of interest, are lactic acid bac-
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teria (LAB). LAB are gram-positive, catalase-nega-
tive, non-sporulating, usually non-motile rods and 
cocci that utilize carbohydrates fermentatively and 
form lactic acid as major end product (Gerbaldo et 
al., 2012). These bacteria are mainly divided into four 
genera: Lactococcus, Lactobacillus, Leuconostoc and 
Pediococcus. They have been used in the food pro-
cessing industry for decades because of their fermen-
tative and food preserving abilities. They have also 
displayed mycotoxin binding abilities (Dalie et al., 
2010). The interaction mechanism between LAB and 
mycotoxins is thought to be similar to the interactions 
involved in adsorption by GMA. It appears that the
polysaccharide components (glucans and mannans) are 
common sites for binding, with different toxins having 
different binding sites. Several authors have concluded 
that the strength of the mycotoxin-LAB interaction is 
infl uenced by the peptidoglycan structure and, more 
precisely, by its amino acid composition (Dalie et al., 
2010). The most extensively investigated mycotoxin 
binding LAB are strains of Lactobacillus rhamnosus. 
L. rhamnosi strains have a demonstrated in vitro bin-
ding capability of DON, T-2, ZON, FB1, AFB1 and 
OTA (El-Nezami et al., 1998; El-Nezami et al., 2002a; 
El-Nezami et al., 2002b; Niderkorn et al., 2006; Pio-
trowska and Zakowska, 2005). However, the in vitro 
adsorption capacity is strain and dose dependent, and 
it is a reversible process balancing between adsorption 
and desorption (Kankaanpaa et al., 2000; Lee et al., 
2003). All the available literature on LAB-mycotoxin 
interactions is based on in vitro results. To date, no in 
vivo trials have been conducted to effectively demon-
strate their mycotoxin binding potential, and therefore 
caution regarding their effectiveness is recommended.
      
Mycotoxin modifi ers
Another strategy to control mycotoxicoses in ani-
mals is the application of microorganisms and their 
enzymes, called mycotoxin modifi ers or mycotoxin 
biotransforming agents. These products biodegrade or 
biotransform mycotoxins into less toxic metabolites. 
They can be divided into four classes: bacteria, yeasts, 
fungi and enzymes. They act in the intestinal tract of 
animals prior to the absorption of mycotoxins. It has to 
be pointed out that for the effective use of mycotoxin 
modifi ers as feed additives, certain prerequisites should 
be fulfi lled. Those include rapid degradation, degrada-
tion into non-toxic (or far less toxic) metabolites under 
different oxygen conditions and in a complex environ-
ment, preserve the organoleptic and nutritive properties 
of the feed, safety of use and stability along the intes-
tinal tract at different pH levels. In addition, the choice 
of the biodegradation approach depends on its practical 
and economical feasibility (Awad et al., 2010; Kolo-
sova and Stroka, 2011). Anaerobic microorganisms 
isolated from animal gut contents are generally suitable 
for developing feed additives, which act in the animals’ 
intestines (Zhou et al., 2008). Survival and adaptation of 
the microorganisms in the animal gut are key factors for 
successful detoxifi cation (Zhou et al., 2008).
   Bacteria
Mycotoxin degrading bacteria have been isolated 
from diverse matrices, such as rumen and intestinal 
microbiota, soil and even water. The most extensively 
investigated mycotoxin degrading microorganism is 
the Eubacterium BBSH 797 strain, originally isolated 
from bovine rumen fl uid. This bacterial strain produces 
enzymes (de-epoxidases) that degrade trichothecenes 
by selective cleavage of their 12,13-epoxy group, 
which is important for the toxicity of these myco-
toxins. This detoxifi cation has been investigated for 
several trichothecenes (Fuchs et al., 2002), and the 
mode of action has been proven in vitro and in vivo 
(Schatzmayr et al., 2006). During its manufacture, 
BBSH 797 is stabilized by freeze-drying and embed-
ding into protective substances (mainly organic poly-
mers) to guarantee stability when passing through the 
acidic gastric tract of animals (Heidler and Schatz-
mayr, 2003). Eubacterium BBSH 797 is currently the 
only microorganism available for commercial purpo-
ses (He et al., 2010).
A variety of other bacterial strains has shown 
mycotoxin degrading abilities in vitro. For example, 
Nocardia asteroides, Corynebacterium rubrum,
Mycobacterium fl uoranthenivorans, Rhodococcus
erythropolis, Flavobacterium aurantiacum and Pseu-
domonas fl uorescens (EFSA, 2009). However, none of 
them have been investigated in vivo. 
    
Yeast
Only one yeast, Trichosporon mycotoxinivorans, 
has been thoroughly investigated regarding its myco-
toxin degrading abilities, which has resulted in its 
commercial use. This yeast, derived from the hindgut 
of the termite Mastotermes darwiniensis, was isolated 
and characterized previously by Molnar et al. (2004). 
This yeast is able to modify ZON and OTA into non-
toxic metabolites. ZON is detoxifi ed by opening the 
macrocyclic ring at the ketogroup at C-6. The meta-
bolite shows no estrogenic effect in a yeast bioassay, 
and does not interact with the estrogen receptor in an 
in vitro assay. The detoxifi cation of OTA occurs by 
the cleavage of the phenylalanine moiety from the 
isocoumarin derivate, producing OTα (Schatzmayr 
et al., 2006). The detoxifi cation of OTA occurs fast. 
After 2.5 hours, a conversion of almost 100% is ob-
served in vitro. For ZON on the other hand, only after 
24 hours of incubation, the mycotoxin is completely 
metabolized. This questions its practical use towards 
this mycotoxin, because detoxifi cation should occur 
fast after ingestion (<8 hours). The use of T. myco-
toxinivorans as a mycotoxin modifi er against OTA is 
promising. A study by Politis et al. (2005) demonstra-
ted that the inclusion of this yeast (105 CFU/g) in the 
diet alleviated the immunotoxic effects of OTA (0.5 
mg/kg) in broiler chickens.
Other potential OTA degrading yeasts are Phaf-
fi a rhodozyma and Xanthophyllomyces dendrorhous 
(Peteri et al., 2007), but they have not been well cha-
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racterized, and their practical application at present is 
limited. Styriak and Conkova (2002) reported that two 
out of several tested Saccharomyces cerevisiae strains 
are able to degrade FB1, but only for 25 or 50% after 
fi ve days of incubation, which is therefore unusable 
in practice.
Fungi
Fungi can not only produce mycotoxins, some of 
them are also able to degrade them. The fungal strains 
Aspergillus niger, A. fl avus, Eurotium herbariorum 
and Rhizopus sp. are able to convert AFB1 to afl atoxi-
col (AFL) by reducing the cyclopentenone carbonyl 
of AFB1 (Wu et al., 2009). AFL has been reported to 
be 18 times less active than the parent compound, but 
it still has carcinogenic properties (Pawlowski et al.,
1977), raising the question if this is an appropriate
detoxifi cation strategy. Other fungal strains have 
shown AFB1 metabolizing properties as well, such as 
Penicillium raistrickii, although their metabolization 
products have almost similar toxicity (AFB2) or have 
not yet been identifi ed (Wu et al., 2009).
Next to their AFB1 degrading potential, Rhizopus 
isolates have also shown ZON detoxifying abilities. 
The selected isolates include strains of R. stolonifer, 
R. oryzae and R. microsporus (Varga et al., 2005). 
Further studies are needed to identify the ZON degra-
ding enzymes in the isolates. A preliminary study has 
been performed to screen twelve black Aspergillus 
strains for their ZON transformation activity by the 
incubation in contaminated culture medium. Analyses 
have shown that ZON is removed after 48 hours of 
incubation by two A. niger strains (EFSA, 2009).
Aspergillus niger is also able to degrade OTA to 
the less toxic compound ochratoxin alpha (OTα). It 
is subsequently degraded into an unknown compound 
(Varga et al., 2000).
Fumonisin degrading fungi have been identifi ed 
as well. Exophalia spinifera and Rhinocladiella atro-
virens extensively metabolize fumonisin B1 to HFB1 
and free tricarballylic acid via esterases (Blackwell et 
al., 1999). 
Enzymes
An attractive alternative to the use of live microbes 
to counteract mycotoxins in animal feed is the appli-
cation of enzymes responsible for the degradation of
mycotoxins. Enzymatic reactions offer a specifi c, of-
ten irreversible, effi cient and environmentally friendly 
way of detoxifi cation that leaves neither toxic resi-
dues nor undesired by-products (Kolosova and Stroka, 
2011). These mycotoxin degrading enzymes are
primarily produced by microorganisms.
Epoxidases are enzymes which are able to detoxify 
trichothecenes by transforming their epoxy group into 
diene groups (Schatzmayr et al., 2006). For example, 
DON can be detoxifi ed to its de-epoxy form, DOM-1.
Takahashi-Ando et al. (2002) reported that ZON 
is converted into a less estrogenic product by the 
cleavage of the lactone structure. The responsible en-
zyme is a lactonohydrolase, originating from the fun-
gus Clonostachys rosea IFO 7063.
Pitout (1969) presented the fi rst in vitro hydrolysis 
of OTA by carboxypeptidase A and, in lower amounts, 
by α-chymotrypsin. Abrunhosa et al. (2006) reported 
the ability of several commercial proteases to hydro-
lyze OTA into OTα. After an incubation period of 25 
hours, a signifi cant hydrolytic activity is detected for 
protease A (87.3%) and for pancreatin (43.4%).
Recently, two genes of Sphingopyxis sp. MTA 144 
responsible for the detoxifi cation of FB1 have been 
identifi ed, and recombinant enzymes have been pro-
duced (Heinl et al., 2010). The degradation of FB1 
consists of two consecutive pathways. FB1 is fi rst me-
tabolized to HFB1 by a carboxylesterase, followed by 
an aminotransferase, which deaminates HFB1, leading 
to an even less toxic compound.
      
EC REGULATIONS ON MAXIMUM LEVELS 
OF MYCOTOXINS IN ANIMAL FEED
The growing awareness that mycotoxins are a great 
concern to animal health has led to regulations of maxi-
mum allowed contamination levels in feed in many 
countries (van Egmond et al., 2007). In Europe, these 
levels have been defi ned by European Commission 
(EC) Regulations and Recommendations. The maxi-
mum levels set are infl uenced by several factors. One 
of the most important factors is species susceptibility. 
As mentioned, pigs are the most susceptible species 
for several major mycotoxins, including DON, ZON 
and OTA. As a result, the maximum levels in feed for 
pigs are lower than for less susceptible species, such 
as poultry. Maximum levels may also differ within one 
species. Piglets and gilts are more susceptible to the 
estrogenic effects of ZON than sows and fattening pigs, 
resulting in lower maximum ZON contamination levels 
for those subcategories. The toxicity of the mycotoxin 
itself is a key determining factor. AFB1 has long been 
known to be acutely toxic and even carcinogenic after 
chronic exposure, resulting in very low guidance va-
lues. Next to the toxicodynamic properties, the kinetic 
properties of mycotoxins also play a role. Fumonisins 
for example have a very low oral bioavailability, ± 
3.5% in pigs (Martinez-Larranaga et al., 1999), and 
consequently, only low concentrations reach the tar-
get tissues. Hence, this allows higher contamination 
levels in feed. Maximum limits have been established 
for complete feed as well as for main feed materials 
(i.e. maize and cereals). In general, maximum set le-
vels are higher for feed materials than for complete 
feedingstuffs. Nevertheless, it should be taken into ac-
count that if a component’s proportion in the daily 
ration of animals is higher than in common practice, 
this should not lead to the animal being exposed to a 
higher level of these mycotoxins than normal.
EC Regulations for AFB1 in feed have been es-
tablished by Directive 2002/32/EC of the European 
Parliament and of the Council of 7 May 2002 on un-
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Mycotoxin Products intended for animal feed Guidance value
  in mg/kg (ppm)
  relative to a
  feedingstuff with
  a moisture
  content of 12%
Deoxynivalenol Feed materials (*)
 - Cereals and cereal products (**) with the exception of maize by-products 8
 - Maize by-products 12
 Complementary and complete feedingstuffs with the exception of: 5
 - Complementary and complete feedingstuffs for pigs 0.9
 - Complementary and complete feedingstuffs for calves (<4 months), 2
    lambs and kids 
Zearalenone Feed materials (*)
 - Cereals and cereal products (**) with the exception of maize by-products 2
 - Maize by-products 3
 Complementary and complete feedingstuffs
 - Complementary and complete feedingstuffs for piglets and gilts (young sows) 0.1
 - Complementary and complete feedingstuffs for sows and fattening pigs 0.25
 - Complementary and complete feedingstuffs for calves, dairy cattle, sheep 0.5
   (including lambs) and goat (including kids) 
Ochratoxin A Feed materials (*)
 - Cereals and cereal products (**) 0.25
 Complementary and complete feedingstuffs
 - Complementary and complete feedingstuffs for pigs 0.05
 - Complementary and complete feedingstuffs for poultry 0.1
Fumonisin B1+B2 Feed materials (*)
 - Maize and maize products (***) 60
 Complementary and complete feedingstuffs for:
 - Pigs, horses (Equidae), rabbits and pet animals 5
 - Fish 10
 - Poultry, calves (<4 months), lambs and kids 20
 - Adult ruminants (>4 months) and mink 50
Afl atoxin B1 All feed materials (*) 0.02
 Complete feedingstuffs for cattle, sheep and goat with the exception of: 0.02
 - Complete feedingstuffs for dairy animals 0.005
 - Complete feedingstuffs for calves and lambs 0.01
 Complete feedingstuffs for pigs and poultry (except young animals) 0.02
 Other complete feedingstuffs 0.01
 Complementary feedingstuffs for cattle, sheep and goats 0.02
 (except complementary feedingstuffs for dairy animals, calves and lambs)
 Complementary feedingstuffs for pigs and poultry (except young animals) 0.02
 Other complementary feedingstuffs  0.005
(*) Particular attention has to be paid to cereals and cereal products fed directly to the animals that their use in a daily ration should not lead to the animal 
being exposed to a higher level of these mycotoxins than the corresponding levels of exposure where only the complete feedingstuffs are used in a daily 
ration.
(**) The term ‘Cereals and cereal products’ includes not only the feed materials listed under heading 1 ‘Cereal grains, their products and by-products’ of 
the non-exclusive list of main feed materials referred to in part B of the Annex to Council Directive 96/25/EC of 29 April 1996 on the circulation and 
use of feed materials (OJ L125, 23.5.1996, p. 35) but also under feed materials derived from cereals in particular cereal forages and roughages.
(***) The term ‘Maize and maize products’ includes not only the feed materials derived from maize listed under heading 1 ‘Cereal grains, their products 
and by-products’ of the non-exclusive list of main feed materials referred to in the Annex, part B of Directive 96/25/EC but also other feed materials 
derived from maize in particular maize forages and roughages.
Table 2. The guidance values on the presence of deoxynivalenol, zearalenone, ochratoxin A and fumonisins in products 
intended for animal feeding as determined in the Commission Recommendation of 17 August 2006 (2006/576/EC), maxi-
mally allowed values on the presence of afl atoxin B1 in products intended for animal feeding as determined by EC Direc-
tive 2002/32/EC of the European Parliament and of the Council of 7 May 2002 (2002/32/EC).
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desirable substances in animal feed (European Com-
mission, 2002). The guidance values for the presence 
of DON, ZON, OTA and fumonisins in products in-
tended for animal feeding have been determined in 
the Commission Recommendation of 17 August 2006 
(European Commission, 2006). These limits are pre-
sented in Table 2. 
In 2011, the European Food Safety Authority 
(EFSA) determined a tolerable daily intake (TDI) for 
the sum of T-2 and its major metabolite, HT-2, of 100 
ng/kg BW (EFSA, 2011a). Just recently, the EC has 
made a proposition regarding these toxins in grains 
and complete feedingstuffs (European Commission, 
2013) (Table 3). For the Fusarium mycotoxins, BEA 
and ENNs, which have recently become of interest, no 
maximum levels nor TDIs have been put forward. The 
EFSA is currently establishing its opinion on the risks 
to human and animal health related to the presence 
of BEA and ENNs in food and feed. The results are 
expected at the latest in September 2014.
CONCLUSION
In this review, several methods to counteract myco-
toxin production and its impact on animal health are 
described. These include pre- and post-harvest strate-
gies and the use of mycotoxin detoxifi ers. In order to 
reduce the risk of mycotoxicosis in animals, several 
methods should be applied simultaneously.
The current legislation regarding maximum, 
guidance or action levels of mycotoxin contamination 
in various feedstuffs is given. This allows the agricul-
tural industry to interpret feed analysis results and to 
decide whether to undertake actions or not.
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